Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Standardized Spinal Mixture is a combination analgesic solution used for intrathecal administration, primarily in the context of obstetric anesthesia for cesarean sections. The mixture typically comprises hyperbaric bupivacaine, a local anesthetic that blocks voltage-gated sodium channels to provide surgical anesthesia; fentanyl, a rapid-onset mu-opioid receptor agonist for immediate intraoperative analgesia; and preservative-free morphine, a long-acting mu-opioid receptor agonist for extended postoperative pain relief. This specific formulation is utilized as a baseline regimen in clinical trials, such as those sponsored by the Icahn School of Medicine at Mount Sinai, to evaluate the efficacy of additional adjuvants like dexmedetomidine or epinephrine in enhancing the duration and quality of the spinal block.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + fentanyl + morphine.